Trial intelligence / Profile preview

Vitamin D Effects on Iron Metabolism in CKD

NCT03073369Phase 4Withdrawn

Sponsor
University of Alabama at Birmingham
Start
Jan 2018
Primary completion
Dec 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of vitamin d in Vitamin D deficiency (VDD), anemia of chronic kidney disease (CKD-A), sponsored by University of Alabama at Birmingham. Planned start Jan 2018; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)anemia of chronic kidney disease (CKD-A)

Beyond the preview

Go deeper on NCT03073369.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03073369.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call